Madrigal Pharmaceuticals (MDGL) Leases (2019 - 2025)
Madrigal Pharmaceuticals (MDGL) has disclosed Leases for 7 consecutive years, with $4.9 million as the latest value for Q4 2025.
- Quarterly Leases rose 105.71% to $4.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, up 105.71% year-over-year, with the annual reading at $4.9 million for FY2025, 105.71% up from the prior year.
- Leases for Q4 2025 was $4.9 million at Madrigal Pharmaceuticals, down from $5.4 million in the prior quarter.
- The five-year high for Leases was $5.9 million in Q2 2025, with the low at $411000.0 in Q2 2023.
- Average Leases over 5 years is $1.9 million, with a median of $1.3 million recorded in 2022.
- The sharpest move saw Leases crashed 61.12% in 2023, then skyrocketed 302.61% in 2025.
- Over 5 years, Leases stood at $797000.0 in 2021, then fell by 24.47% to $602000.0 in 2022, then surged by 184.55% to $1.7 million in 2023, then skyrocketed by 40.16% to $2.4 million in 2024, then surged by 105.71% to $4.9 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $4.9 million, $5.4 million, and $5.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.